Epigenomics投稿须知

期刊简介

《Epigenomics》是由Future Medicine Ltd.出版社于2009年创办的英文国际期刊（ISSN: 1750-1911，E-ISSN: 1750-192X），该期刊长期致力于遗传学领域的创新研究，主要研究方向为GENETICS & HEREDITY。作为SCIE收录期刊（JCR分区 Q2，中科院 4区），本刊采用OA未开放获取模式（OA占比0.2504...%），以发表遗传学领域等方向的原创性研究为核心（研究类文章占比61.29%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在93篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Epigenomics审稿周期约为 12周，或约稿。该刊近年未被列入国际预警名单，年发文量约93篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
93 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	GENETICS & HEREDITY 遗传学 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	GENETICS & HEREDITY 遗传学 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：GENETICS & HEREDITY	SCIE	Q2	77 / 191	59.9%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：GENETICS & HEREDITY	SCIE	Q2	88 / 191	54.19%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：5.8

SJR：0.751

SNIP：0.475

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Genetics	Q2	138 / 347	60%
大类：Biochemistry, Genetics and Molecular Biology 小类：Cancer Research	Q2	113 / 230	51%

期刊发文

Combining EZH2 inhibitors with other therapies for solid tumors: more choices for better effects
Author: Huang, Rong; Wu, Yirong; Zou, Zhengyun

Journal: EPIGENOMICS. 2023; Vol. 14, Issue 22, pp. 1449-1464. DOI: 10.2217/epi-2022-0320
miR-4732-3p prevents lung cancer progression via inhibition of the TBX15/TNFSF11 axis
Author: Li, Pengfei; Li, Ying; Bai, Shuping; Zhang, Yu; Zhao, Ling

Journal: EPIGENOMICS. 2023; Vol. , Issue , pp. -. DOI: 10.2217/epi-2023-0009
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma
Author: Xie, Tongji; Fan, Guangyu; Huang, Liling; Lou, Ning; Han, Xiaohong; Xing, Puyuan; Shi, Yuankai

Journal: EPIGENOMICS. 2023; Vol. 14, Issue 22, pp. 1427-1448. DOI: 10.2217/epi-2022-0282
Low-dose 5-aza-2' -deoxycytidine protects against early renal injury by increasing klotho expression
Author: Zhao, Yanlong; Zeng, Xiaorong; Xu, Xinli; Wang, Wenjing; Xu, Lei; Wu, Yiying; Li, Hang

Journal: EPIGENOMICS. 2023; Vol. , Issue , pp. -. DOI: 10.2217/epi-2022-0430
Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma
Author: Luo, Huiyan; Jiang, Qiyin; Luo, Yuehua; Yang, Miaolun; Yu, Yifan; Yu, Chengyang; Wang, Xiongwen

Journal: EPIGENOMICS. 2023; Vol. , Issue , pp. -. DOI: 10.2217/epi-2022-0291
tRF-20-S998LO9D inhibits endometrial carcinoma by upregulating SESN2
Author: Qian, Tianye; Yu, Xinnian; Xu, Andi; Li, Huixin; Chen, Wei; Zhong, Shanliang

Journal: EPIGENOMICS. 2023; Vol. 14, Issue 24, pp. 1563-1577. DOI: 10.2217/epi-2022-0349
Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats
Author: Ma, Jinhu; You, Dandan; Chen, Shuwen; Fang, Nana; Yi, Xinrui; Wang, Yi; Lu, Xuejin; Li, Xinyu; Zhu, Meizi; Xue, Min; Tang, Yunshu; Wei, Xiaohui; Huang, Jianzhen; Zhu, Yaling

Journal: EPIGENOMICS. 2023; Vol. 14, Issue 23, pp. 1523-1540. DOI: 10.2217/epi-2022-0362
N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer
Author: Wu, Jun; Wang, Xiaoqin; Li, Xin

Journal: EPIGENOMICS. 2023; Vol. 14, Issue 23, pp. 1509-1522. DOI: 10.2217/epi-2022-0403

Epigenomics

表观基因组学

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询